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involvementTo the Editor,
Multiple myeloma (MM) is a systemic disease with neo-
plastic proliferation of a single plasma cell clone. Although
MM with cavernous sinus involvement is rare in neurological
practice, a previous study has shown that it may cause
cranial nerve neuropathy [1].
A 57-year-old male with no systemic disease complained
of chest pain for 8 months and diplopia for 3 weeks. He
presented to the hospital, where a computed tomography
(CT) scan of the chest andmagnetic resonance imaging (MRI)
of the brain were performed. Results of the chest CT scan
revealed a mass at the right chest wall, and the brain MRI
(Fig. 1Ae1C) demonstrated a tumor in the sphenoid sinus,
with extension to the right cavernous sinus. Right abducens
nerve palsy was noted during the examination. We per-
formed a pterional craniotomy to remove the cavernous
sinus tumor. During surgery, we injected fibrin glue into the
cavernous sinus, between the ophthalmic branch (V1) and
the maxillary branch (V2) of the trigeminal nerve, to prevent
massive bleeding (Fig. 1G). The tumor was almost totally
removed. A pathological analysis showed plasmacytoma,
with l-type light chain positive surface markers, compatible
with the tumor at the right chest wall. We also examined the
bone marrow, and confirmed the diagnosis of MM, immuno-
globulin G-l type. The sixth nerve neuropathy gradually
improved postoperatively. The patient was then referred to
an oncologist for chemotherapy. MRI follow-up was arranged
6 months postoperatively (Fig. 1De1F), which revealed no
local recurrence. There was also no new or residual cranial
neuropathy after the surgery.1607-551X/$36 Copyright ª 2013, Kaohsiung Medical University. Publish
http://dx.doi.org/10.1016/j.kjms.2013.01.008The use of an endoscopic transsphenoidal approach for
sphenoidal sinus plasmacytoma with cavernous sinus inva-
sion has been reported in a previous study [2]. Right
abducens palsy was also found in that case. The surgeons
chose the endoscopic transsphenoidal approach for this
sphenoid sinus plasmacytoma and successfully removed
that part of the tumor in the sphenoid sinus. However, the
residual tumor in the cavernous sinus was not treated
because of the difficulty in controlling hemostasis using the
endonasal endoscopic approach. Radiotherapy was per-
formed 1 month after the surgery and the cranial nerve
palsy recovered about 4 months after the surgery. The
cavernous sinus has been considered a “no man’s land”
because of the poor understanding of its surgical anatomy
and difficulty in establishing hemostasis within the cav-
ernous sinus [3]. Fibrin glue, a so-called fibrin sealant for
hemostasis, has been used to facilitate approach to cav-
ernous sinus tumors [3] and was introduced into our
department by Dr Hsu (the second author). The fibrin glue is
injected between the V1 and V2 branches of the trigeminal
nerve to obliterate the lateral cavernous sinus compart-
ment. Injecting the glue posterior to the clinoidal segment
of the internal carotid artery obliterates the medial cav-
ernous sinus compartment. Reestablishment of the flow in
the cavernous sinus can be seen on the follow-up angiog-
raphy 2e3 months postoperatively, proving that this is
a safe method for hemostasis of the cavernous sinus [3]. In
our case, immediate decompression of the cranial nerve
was achieved through the transcavernous approach, and
may have increased the possibility of the cranial nerve
recovering. Using this technique we can obtain gooded by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (AeC) Slightly heterogeneous contrast-enhanced tumor (green arrow), about 28 mm in the sphenoid sinus with
extension to the right cavernous sinus in the T1-weighted magnetic resonance image (MRI). (DeF) Remarkable regression of tumor
size is seen in the follow-up MRI 6 months postoperatively. (G) Fibrin glue is injected between V1 (green rectangle) and V2 (pink
rectangle) for hemostasis. The cavernous sinus (yellow circle) is well exposed for tumor removal.
518 Letter to the Editorsurgical visualization and less blood loss when approaching
these cavernous sinus lesions.
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